Pfizer, Moderna, Regeneron and many other healthcare companies presented at the 40th annual J.P. Morgan Healthcare Conference and outlined their plans to continue fighting Covid this year.
marked the 40th annual J.P. Morgan Healthcare conference, one of the biggest industry events of the year. The conference, held virtually this year, featured hundreds of companies across the sector discussing their accomplishments in 2021 and what they expect for 2022. Of course, dominating every discussion was the ongoing Covid-19 pandemic, and several companies directly involved in developing Covid-19 treatments, vaccines and tests.
Moderna CEO Stephane Bancel highlighted the growth of his company’s vaccine business, which shipped 807 million doses in 2021 and took in over $17 billion in revenue. The company’s next big thing is its work on a vaccine that can tackle multiple respiratory viruses at once. It’s currently doing clinical trials for a Covid/flu combination and plans to expand that over the next few years to include RSV and even a common cold. “We think this is in reach,” Bancel said.In 2021, Regeneron delivered 2.
Pfizer announced at the conference that it’s preparing to manufacture 120 million doses of its Covid antiviral treatment, Paxlovid. That’s more than it currently has pre-orders for. Bourla said this is because the company anticipates high levels of orders from governments for stockpiling purposes.
Deutschland Neuesten Nachrichten, Deutschland Schlagzeilen
Similar News:Sie können auch ähnliche Nachrichten wie diese lesen, die wir aus anderen Nachrichtenquellen gesammelt haben.
Pfizer says it applied for Japan gov't approval for oral COVID-19 drugTOKYO (Reuters) -U.S. drugmaker Pfizer Inc said on Friday it has applied for Japanese government approval for its oral COVID-19 treatment. The application is based on global Phase II/III trials that Japan was part of, Pfizer said in a statement. With COVID-19 cases surging again, Japan is betting heavily on oral treatments to keep serious infections and deaths at bay.
Weiterlesen »
As omicron drives surge in COVID-19 cases, HealthCare.gov sign-up deadline arrivesPeople looking for health insurance in the grip of the omicron surge have through Saturday to sign up for taxpayer-subsidized private coverage under the Obama-era Affordable Care Act.
Weiterlesen »
Biden to double free COVID tests, add N95s, to fight omicron | AP NewsWASHINGTON (AP) — President Joe Biden announced Thursday that the government will double to 1 billion the rapid, at-home COVID-19 tests to be distributed free to Americans, along with the most protective N95 masks, as he highlighted his efforts to “surge” resources to help the country weather the spike in coronavirus cases.
Weiterlesen »
Nurses rally in Chicago to call for better hospital staffing amid rising COVID casesNurses in Chicago and across the nation are taking part in a national day of action Thursday, to call attention to what they are calling a staffing crisis.
Weiterlesen »
Chinese woman stuck in blind date's home by sudden Covid lockdownA woman in China was trapped in her blind date's apartment after authorities in the city of Zhengzhou imposed a Covid-19 lockdown.
Weiterlesen »
Omicron tests China's ability to hold Olympics with 'zero-tolerance' COVID-19 policyThe omicron variant poses a test to China's “zero-tolerance” COVID-19 policy and its ability to successfully host the Winter Olympics.
Weiterlesen »